Alverix Inc., of San Jose, Calif., named James D. Merselis president and CEO, and a member of the board of directors...Amsterdam Molecular Therapeutics, of Amsterdam, the Netherlands, appointed Janneke de Wal director global marketing and sales

Exiqon, of Vedbaek, Denmark, appointed Cynthia K. French chief scientific officer and Erik Holmlin chief commercial officer...Ikonysis, of New Haven, Conn., named Louise Mawhinney senior vice president and chief financial officer...PharmAthene Inc., of Annapolis, Md., appointed Jordan P. Karp senior vice president and general counsel

Alpharma Inc., of Bridgewater, N.J., appointed Ron Warner executive vice president and chief scientific officer and named R. Scott Shively senior vice president of pharmaceutical commercial operations...Althea Technologies Inc., of San Diego, named E. J. Brandreth vice president of quality and regulatory

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board

Adolor Corp., of Exton, Pa., promoted Lee Techner to vice president of medical affairs and medical director...It also named Guido Magni to its board and the governance and nominating committee

VirtualHealth Technologies Inc., of Lexington, Ky., named Robert Tapales vice president of operations. Westfield Capital Management, of Boston, named Lawrence C. Fritz Life Sciences Venture Partner. WuXi PharmaTech, of Shanghai, China, appointed Peng Wang vice president of discovery biology. XTL Biopharmaceuticals Ltd., of Valley College, N.Y., appointed Laurence N. Charney to its board.

Stem Cell Therapeutics Corp., of Calgary, Alberta, named Thomas Franck vice president of commercial planning. Trius Therapeutics Inc., of San Diego, appointed Paul Truex to its board. VentiRx Pharmaceuticals Inc., of San Diego, named Elliott Grossbard to its board.

Premier Research Group plc, of Philadelphia, appointed Anthony Faragasso, executive director and global head of medical management and safety...Somnus Therapeutics Inc., of Bedminster, N.J., named Gary Cupit, Mary Osbakken, Christine Blumhardt, Linda Hogan and Anne McCormick to its executive development team

Altus Pharmaceuticals Inc., of Cambridge, Mass., appointed Georges Gemayel, CEO and member of the board...Ariad Pharmaceuticals Inc., of Cambridge, Mass., appointed Raymond T. Keane vice president, general counsel and chief compliance officer...Endo Pharmaceuticals Holdings Inc., of Chadds Ford, Pa., named Blaine T. Davis vice president of investor relations and corporate communications

Sigma-Aldrich, of St. Louis, said Chief Administrative Officer and Chief Financial Officer Michael R. Hogan will retire this summer...He will become an unpaid vice president and outside director of the Sigma-Aldrich Foundation...Vyteris Inc., of Fair Lawn, N.J., appointed Haro Hartounian president and Joseph Himy chief financial officer

Aegera Therapeutics Inc., of Montreal, appointed Jeremy Curnock Cook and Gary Littlejohn to its board...Aquapharm Biodiscovery Ltd., of Oban, Scotland, appointed Douglas Thomson commercial director and named Axel Kleemann to its board...Cephalon Inc., of Frazer, Pa., appointed Jerry Pappert executive vice president and general counsel

Medivation Inc., of San Francisco, appointed Michele D. Bronson vice president, regulatory and quality...Minrad International Inc., of Orchard park, N.Y., appointed David T. DiGiacinto president and chief operating officer...Monogram Biosciences Inc., of South San Francisco promoted Gordon Parry to vice president, research and development, oncology

Febit group, of Medford, Mass., and Heidelberg, Germany, announced its new scientific advisory board with Mark Chee chairman, Karoly Nikolich vice chairman and David Lockhart, Mostafa Ronaghi and Jeffrey Trent as members

MPM Capital, of Boston, appointed Robert Millman and Elizabeth Stoner executive partners...Oragenics Inc., of Alachua, Fla., appointed Derek Hennecke and Stanley B. Stein to its board of directors...Predictive Biosciences, of Lexington, Mass., appointed Peter Klemm president, director and CEO

The company also established a strategic commercialization and partnership committee consisting of directors Peter D. Kiernan III, Neil W. Flanzraich and Georg Nebgen...Modigene Inc., of Nes-Ziona, Israel, named Marian Gorecki and Steven D. Rubin to its board and appointed Phillip Frost chairman

Memory Pharmaceuticals Corp., of Montvale, N.J., appointed Vaughn M. Kailian interim president and CEO...Jim Sulat, the previous president and CEO, will be chief financial executive on a part-time basis...OPKO Health Inc., of Miami, appointed Thomas E. Beier and Richard C. Pfenniger Jr

Biomedical Corp., of San Diego, appointed Punit S. Dhillon vice president of finance and operations...Biophan Technologies Inc., of Pittsford, N.Y., appointed Harold Gubnitsky, John Lanzafame and Travis E. Baugh to its board of directors

Affitech AS, of Oslo, Norway, appointed Sergej Kiprijanov vice president of discovery research and preclinical development...Alnylam Pharmaceuticals Inc., of Cambridge, Mass., appointed Edward Scolnick to its board of directors and scientific advisory board...AlphaVax, of Research Triangle Park, N.C., appointed Mark Schleiss, David Bernstein, Robert Pass and Paul D. Griffiths to its cytomegalovirus advisory board and named Robert Olmsted as chairman

Samaritan Pharmaceuticals Inc., of Las Vegas, named Jack L. Ayala and Robert W. Crane to its board of directors...ViroPharma Inc., of Exton, Pa., named Thomas F. Doyle vice president of strategic initiatives and appointed J. Peter Wolf vice president, general counsel and secretary of the board of directors